Trials / Completed
CompletedNCT00456924
Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
Prospective Randomized Multicenter Phase II Study of the Dose-Response Effects of Continuous Administration of Low-Dose VA2914 on Parameters of the Hypothalamic-Pituitary-Gonadal Axis and the Endometrium
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (planned)
- Sponsor
- HRA Pharma · Industry
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the present study is to evaluate continuous administration of low doses of VA2914 for potential contraceptive activity and effects on the menstrual cycle and steroid hormone parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VA2914 |
Timeline
- Start date
- 2004-01-01
- Completion
- 2004-12-01
- First posted
- 2007-04-05
- Last updated
- 2010-06-17
Locations
4 sites across 2 countries: Belgium, France
Source: ClinicalTrials.gov record NCT00456924. Inclusion in this directory is not an endorsement.